CSIMarket
 


Foamix Pharmaceuticals Ltd   (FOMX)
Other Ticker:  
 
 

FOMX's Revenue Growth by Quarter and Year

Foamix Pharmaceuticals Ltd 's Revenue results by quarter and year




FOMX Revenue (in millions $) FY 2019 FY 2018 FY 2017 FY 2016
IV Quarter December 0.14 0.86 2.12 0.00
III Quarter September 0.00 0.87 0.80 0.11
II Quarter June 0.00 0.96 0.75 0.00
I Quarter March 0.31 0.91 0.85 5.41
FY   0.45 3.60 4.52 5.52



FOMX Revenue fourth quarter 2019 Y/Y Growth Comment
Foamix Pharmaceuticals Ltd reported drop in Revenue in the fourth quarter 2019 by -84.3% to $ 0.14 millions, from the same quarter in 2018.
The fall in the fourth quarter 2019 Foamix Pharmaceuticals Ltd 's Revenue compares unfavorably to the Company's average Revenue decline of -27.46%.

Looking into fourth quarter 2019 results within Legal Cannabis industry 12 other companies have achieved higher Revenue growth. While Foamix Pharmaceuticals Ltd ' s Revenue meltdown of -84.3% ranks overall at the positon no. 3740 in the fourth quarter 2019.




FOMX Revenue ( Y/Y Growth %) 2019
2018 2017 2016
IV Quarter December -84.3 % -59.43 % - -
III Quarter September - 8.75 % 627.27 % -
II Quarter June - 28 % - -
I Quarter March -65.93 % 7.06 % -84.29 % -
FY   -87.64 % -20.35 % -18.12 % -

Financial Statements
Foamix Pharmaceuticals Ltd 's fourth quarter 2019 Revenue $ 0.14 millions FOMX's Income Statement
Foamix Pharmaceuticals Ltd 's fourth quarter 2018 Revenue $ 0.86 millions Quarterly FOMX's Income Statement
New: More FOMX's historic Revenue Growth >>


FOMX Revenue (Quarter on Quarter Growth %)

2019
2018 2017 2016
IV Quarter December - -1.15 % 165 % -
III Quarter September - -9.38 % 6.67 % -
II Quarter June - 5.49 % -11.76 % -
I Quarter March -63.95 % -57.08 % - -
FY (Year on Year)   -87.64 % -20.35 % -18.12 % -




Revenue fourth quarter 2019 Y/Y Growth Company Ranking
Within: No.
Legal Cannabis Industry #13
Consumer Non Cyclical Sector #139
Overall #3740

Revenue Y/Y Growth Statistics
High Average Low
-20.43 % -27.46 % -34.49 %
(Dec 31 2018)   (Mar 31 2019)
Revenue fourth quarter 2019 Y/Y Growth Company Ranking
Within: No.
Legal Cannabis Industry #13
Consumer Non Cyclical Sector #139
Overall #3740
Revenue Y/Y Growth Statistics
High Average Low
-20.43 % -27.46 % -34.49 %
(Dec 31 2018)   (Mar 31 2019)

Revenue by Quarter for the Fiscal Years 2016, 2017, 2018, 2019

Foamix Pharmaceuticals Ltd 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


FOMX's IV. Quarter Q/Q Revenue Comment


Revenue Q/Q Growth Company Ranking
Within: No.
Legal Cannabis Industry #
Consumer Non Cyclical Sector #
Overall #
Revenue Q/Q Growth Company Ranking
Within: No.
Legal Cannabis Industry #
Consumer Non Cyclical Sector #
Overall #
Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


FOMX's IV. Quarter Q/Q Revenue Comment


Foamix Pharmaceuticals Ltd 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Dec 31 2019)
12 Months Ending
(Sep 30 2019)
12 Months Ending
(Jun 30 2019)
12 Months Ending
(Mar 31 2019)
12 Months Ending
(Dec 31 2018)
Cumulative Revenue 12 Months Ending $ 0.00 $ 0.00 $ 0.00 $ 3.00 $ 3.60
Y / Y Revenue Growth (TTM) - - - -34.49 % -20.43 %
Year on Year Revenue Growth Overall Ranking # 3638 # 0 # 0 # 3232 # 3639
Seqeuential Revenue Change (TTM) - - - -16.63 % -25.94 %
Seq. Revenue Growth (TTM) Overall Ranking # 3740 # 0 # 0 # 3397 # 2390




Cumulative Revenue growth Comment
Foamix Pharmaceuticals Ltd realized trailing twelve months of $ 0 millions, in the Dec 31 2019, compare to Revenue of $ 4 millions a year ago.

In the Consumer Non Cyclical sector 136 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 0 to 3638.

Revenue TTM Q/Q Growth Statistics
High Average Low
-20.43 %
-27.46 %
-34.49 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Legal Cannabis Industry # 11
Consumer Non Cyclical Sector # 137
Overall # 3638

Revenue TTM Y/Y Growth Statistics
High Average Low
-20.43 %
-27.46 %
-34.49 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 11
Sector # 141
S&P 500 # 3740
Cumulative Revenue growth Comment
Foamix Pharmaceuticals Ltd realized trailing twelve months of $ 0 millions, in the Dec 31 2019, compare to Revenue of $ 4 millions a year ago.

In the Consumer Non Cyclical sector 136 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 0 to 3638.

Revenue TTM Q/Q Growth Statistics
High Average Low
-20.43 %
-27.46 %
-34.49 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Legal Cannabis Industry # 11
Consumer Non Cyclical Sector # 137
Overall # 3638

Revenue TTM Y/Y Growth Statistics
High Average Low
-20.43 %
-27.46 %
-34.49 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 11
Sector # 141
S&P 500 # 3740




Other Revenue Growth
Legal Cannabis Industry Revenue Growth Trends and Statistics
Consumer Non Cyclical Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
FOMX's Revenue Growth Ratio versus Legal Cannabis Industry, Consumer Non Cyclical Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for FOMX's Competitors
Revenue Growth for Foamix Pharmaceuticals Ltd 's Suppliers
Revenue Growth for FOMX's Customers

You may also want to know
FOMX's Annual Growth Rates FOMX's Profitability Ratios FOMX's Asset Turnover Ratio FOMX's Dividend Growth
FOMX's Roe FOMX's Valuation Ratios FOMX's Financial Strength Ratios FOMX's Dividend Payout Ratio
FOMX's Roa FOMX's Inventory Turnover Ratio FOMX's Growth Rates FOMX's Dividend Comparisons



Companies with similar Revenue meltdown for the quarter ending Dec 31 2019 within Consumer Non Cyclical SectorY/Y Change %Revenue for the quarter ending Dec 31 2019
Philip Morris International Inc -0.05%$ -0.045 millions
American Vanguard Corporation-0.62%$ -0.621 millions
Edgewell Personal Care Company-0.68%$ -0.678 millions
Vector Group Ltd-0.73%$ -0.731 millions
Willamette Valley Vineyards Inc -0.87%$ -0.874 millions
Nutrien Ltd.-1.94%$ -1.940 millions
Fresh Del Monte Produce Inc-1.98%$ -1.979 millions
Sanfilippo John B and Son Inc-2.72%$ -2.721 millions
Kellanova-2.83%$ -2.834 millions
Anheuser busch Inbev Sa-4.19%$ -4.193 millions
Farmer Brothers Co-4.55%$ -4.553 millions
Icl Group Ltd -5.13%$ -5.130 millions
China Green Agriculture Inc -5.15%$ -5.147 millions
Kraft Heinz Co-5.28%$ -5.275 millions
Muliang Viagoo Technology Inc -5.34%$ -5.342 millions
South Dakota Soybean Processors Llc-5.56%$ -5.560 millions
Revlon Inc -5.69%$ -5.690 millions
Arcadia Biosciences Inc -6.31%$ -6.306 millions
Bunge Global Sa-6.58%$ -6.584 millions
Coty Inc -6.62%$ -6.618 millions
Twinlab Consolidated Holdings Inc -6.63%$ -6.629 millions
Cf Industries Holdings inc -7.33%$ -7.332 millions
Jones Soda Co-7.56%$ -7.564 millions
Usana Health Sciences Inc -9.27%$ -9.272 millions
Mannatech Incorporated-10.53%$ -10.531 millions
Scott s Liquid Gold inc -11.52%$ -11.517 millions
Mgp Ingredients Inc -11.81%$ -11.814 millions
Pepsico Inc -11.96%$ -11.965 millions
Cvr Partners Lp-12.29%$ -12.286 millions
Craft Brew Alliance Inc -13.02%$ -13.022 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com